Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factors Associated with Recurrence of Age-Related Macular Degeneration after Anti-Vascular Endothelial Growth Factor Treatment: A Retrospective Cohort Study.

Ophthalmology - 1 Nov 2015

Kuroda Yoshimasa, Yamashiro Kenji, Miyake Masahiro, Yoshikawa Munemitsu, Nakanishi Hideo, Oishi Akio, Tamura Hiroshi, Ooto Sotaro, Tsujikawa Akitaka, Yoshimura Nagahisa

Abstract excerpt

PURPOSE: To investigate the predictive factors associated with recurrence after anti-vascular endothelial growth factor (VEGF) treatment for neovascular age-related macular degeneration (AMD). DESIGN: Retrospective cohort study. PARTICIPANTS: A total of 343 eyes of 326 patients with subfoveal neovascular AMD who were treated with an as-needed regimen after 3 monthly loading doses of intravitreal ranibizumab....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Complement Factor H

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intravitreal Injections

Share to Recurrence

Share to Retreatment

Share to Vascular Endothelial Growth Factor A

Share to Visual Acuity

Share to Wet Macular Degeneration

Source

Identifiers

PMID: 26271842
DOI: 10.1016/j.ophtha.2015.06.053

Genes

ARMS2
CFH

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factors Associated with Recurrence of Age-Related Macular Degeneration after Anti-Vascular Endothelial Growth Factor Treatment: A Retrospective Cohort Study.PMID 26271842Read ↗

ARMS2 A69S polymorphism is associated with the number of ranibizumab injections needed for exudative age-related macular degeneration in a pro re nata regimen during 4 years of follow-up.Semantic proximity Read ↗

Qualitative analysis by OCTA in patients with choroidal neovascularization secondary to angioid streaks as predictors of disease recurrences over timeSemantic proximity Read ↗

Pharmacogenetic associations with long-term response to anti-vascular endothelial growth factor treatment in neovascular AMD patients.Semantic proximity Read ↗

Predictive value of VEGF A and VEGFR2 polymorphisms in the response to intravitreal ranibizumab treatment for wet AMD.Semantic proximity Read ↗

Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.Semantic proximity Read ↗

A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration.Semantic proximity Read ↗

Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.Semantic proximity Read ↗

Predicting non-response to ranibizumab in patients with neovascular age-related macular degeneration.Semantic proximity Read ↗

Genetic factors associated with response to intravitreal ranibizumab in Korean patients with neovascular age-related macular degeneration.Semantic proximity Read ↗

Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.Semantic proximity Read ↗

Recurrence of neovascular age-related macular degeneration after cessation of treat-and-extend regimenSemantic proximity Read ↗

Long-term outcome of neovascular age-related macular degeneration: association between treatment outcome and major risk alleles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.